Clinical Trials Browser

INDUSTRY × Tumor Necrosis Factor-alpha × Dermatologic × Clear all

NCT05222932 2025-08-07

AVENTIL

Phase 1 Active not recruiting

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Melanoma

NCT00002262 2005-06-24

A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma

Phase 1 Completed

DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections